Database Query Results : acetaminophen, ,

acet, acetaminophen: Click to Expand ⟱
Features:

Acetaminophen — Acetaminophen (also called paracetamol; common abbreviation APAP) is a small-molecule analgesic and antipyretic used for pain and fever. It is a non-opioid, non-NSAID analgesic with weak peripheral anti-inflammatory activity compared with NSAIDs, and its clinically relevant actions are largely central (CNS) rather than peripheral. It is widely available OTC and in many combination products; overdose risk is driven by total aggregate APAP exposure across products.

Primary mechanisms (ranked):

  1. Central prostaglandin synthesis suppression via inhibition of prostaglandin H synthase (COX peroxidase site) under low-peroxide conditions → ↓PGE2 signaling (analgesic/antipyretic dominant)
  2. Central neuromodulation (context-dependent): serotonergic descending inhibitory pathways and endocannabinoid-related signaling (including AM404 formation) contributing to analgesia
  3. Thermoregulatory set-point effects in hypothalamus downstream of ↓PGE2 (antipyresis)
  4. High-dose/toxicity mechanism: CYP-mediated bioactivation → NAPQI formation → glutathione depletion, mitochondrial oxidative stress and hepatocellular injury

Bioavailability / PK relevance: Oral acetaminophen is generally well absorbed; therapeutic plasma half-life is typically ~1.5–3 hours in adults, with hepatic clearance dominated by glucuronidation and sulfation; a smaller fraction undergoes CYP oxidation to NAPQI. Hepatotoxic risk increases when detox capacity (glutathione) is compromised or when oxidative bioactivation is increased.

In-vitro vs systemic exposure relevance: Therapeutic effects are not typically driven by high cytotoxic concentrations; many cell-culture toxicity phenotypes reflect supratherapeutic exposure and/or bioactivation contexts not representative of normal systemic dosing.

Clinical evidence status: Established standard-of-care symptomatic therapy (OTC and prescription formulations) for pain and fever; major safety signal is dose-dependent hepatotoxicity from overdose and unintentional “stacking” across combination products.


Pathways:
-Cytochrome P450 Metabolism: NAPQI (N-acetyl-p-benzoquinone imine)
-Excess NAPQI depletes glutathione, a key antioxidant. The absence of sufficient glutathione leads to elevated oxidative stress.
-NF-κB Activation:
-Direct DNA Damage:

Excess results in increased oxidative stress, mitochondrial dysfunction, and ultimately hepatocellular damage (liver injury)

Mechanistic axes relevant to acetaminophen (therapeutic action and dose-limiting toxicity)

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Central prostaglandin synthesis ↔ (not a primary anticancer mechanism) ↓ PGE2 signaling in CNS P–R Analgesia, antipyresis Clinically consistent with central COX/PGHS functional inhibition (peroxidase-site, redox-state dependent) with minimal peripheral anti-inflammatory effect vs NSAIDs.
2 Serotonergic descending pain inhibition ↔ ↑ descending inhibitory tone (context-dependent) P–R Analgesia Frequently described as contributory; magnitude varies by model and co-administered agents.
3 Endocannabinoid-related signaling and TRPV1 (AM404 axis) ↔ ↑ cannabinoid/TRPV1-linked modulation (context-dependent) R Analgesia (adjunctive) AM404 is a CNS metabolite implicated in some mechanistic models; relevance varies across species and experimental systems.
4 ROS and mitochondrial oxidative stress (toxicity axis) ↑ (high concentration only) ↑ (overdose context) R–G Hepatocellular injury Overdose: NAPQI formation + GSH depletion → mitochondrial dysfunction and oxidative stress; this is dose-limiting and not a therapeutic mechanism.
5 NRF2 and glutathione homeostasis (toxicity modifier) ↔ (context-dependent) ↑ adaptive response; ↓ GSH predisposes to injury G Determines resilience to NAPQI Risk is increased when baseline GSH is low (e.g., fasting/starvation) or when metabolism shifts toward oxidation pathways.
6 Clinical Translation Constraint — — — Dose ceiling due to hepatotoxicity risk Major real-world risk is inadvertent overdose from multi-product use; labeling emphasizes total daily maximum across all sources/routes.


Scientific Papers found: Click to Expand⟱
5312- acet,    Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action
*COX1↓, *other?, *BBB↑, TRPV1↑,
5313- acet,    Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
- Review, Nor, NA
*COX2↓,
1478- SFN,  acet,    Anti-inflammatory and anti-oxidant effects of combination between sulforaphane and acetaminophen in LPS-stimulated RAW 264.7 macrophage cells
- in-vitro, Nor, NA
eff↑, NO↓, iNOS↓, COX2↓, IL1β↓, ROS↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↓, 1,  

Cell Death ⓘ

iNOS↓, 1,   TRPV1↑, 1,  

Angiogenesis & Vasculature ⓘ

NO↓, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 1,   IL1β↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Transcription & Epigenetics ⓘ

other?, 1,  

Barriers & Transport ⓘ

BBB↑, 1,  

Immune & Inflammatory Signaling ⓘ

COX1↓, 1,   COX2↓, 1,  
Total Targets: 4

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:275  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page